Walleye Capital
CVS icon

Walleye Capital’s CVS Health CVS Stock Holding History

Walleye Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.19M Sell
50,200
-7,700
-13% -$687K 0.02% 806
2026
Q1 		$4.16M Sell
57,900
-174,100
-75% -$13.4M 0.02% 921
2025
Q4 		$18.4M Buy
232,000
+90,200
+64% +$7.11M 0.06% 327
2025
Q3 		$10.7M Sell
141,800
-33,900
-19% -$2.32M 0.04% 510
2025
Q2 		$12.1M Sell
175,700
-30,400
-15% -$1.99M 0.05% 420
2025
Q1 		$14M Sell
206,100
-30,900
-13% -$1.85M 0.06% 305
2024
Q4 		$10.6M Buy
237,000
+71,800
+43% +$4.03M 0.03% 589
2024
Q3 		$10.4M Sell
165,200
-319,100
-66% -$18.6M 0.02% 673
2024
Q2 		$28.6M Buy
484,300
+170,800
+54% +$10.7M 0.05% 241
2024
Q1 		$25M Buy
313,500
+122,900
+64% +$9.39M 0.04% 320
2023
Q4 		$15M Buy
190,600
+144,500
+313% +$10.3M 0.03% 467
2023
Q3 		$3.22M Sell
46,100
-2,400
-5% -$170K 0.01% 1374
2023
Q2 		$3.35M Buy
48,500
+25,000
+106% +$1.78M 0.01% 977
2023
Q1 		$1.75M Buy
23,500
+12,300
+110% +$1.03M 0.03% 808
2022
Q4 		$1.04M Buy
+11,200
New +$1.08M 0.02% 975
2020
Q1 		– Sell
-11,500
Closed -$854K – 1072
2019
Q4 		$854K Sell
11,500
-4,900
-30% -$344K 0.06% 475
2019
Q3 		$1.03M Buy
16,400
+7,700
+89% +$456K 0.06% 436
2019
Q2 		$474K Buy
8,700
+6,600
+314% +$355K 0.05% 515
2019
Q1 		$113K Buy
+2,100
New +$130K 0.02% 996

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Walleye Capital's CVS Position: Q2 2026 in Review

Walleye Capital increased its CVS Health (CVS) stake by 89,245% in Q2 2026, buying an estimated $72.6M and bringing the position to 813,936 shares worth $84.2M. The position accounts for 0.3% of the portfolio, ranked #33.

Walleye Capital first reported a position in CVS in Q3 2021 and has held it in 14 quarters since. 2,068 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Walleye Capital held 813,936 shares of CVS Health worth $84.2M as of Q2 2026.
  • Walleye Capital bought 813,025 CVS Health shares in Q2 2026, an estimated $72.6M.
  • CVS Health made up 0.3% of Walleye Capital's portfolio in Q2 2026, its #33 holding.
  • Walleye Capital first reported a position in CVS Health in Q3 2021 and has held it in 14 quarters since.
  • 2,068 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.